Effekten på sundhed og livskvalitet De patienter, som blev behandlet med tocilizumab, berettede om forbedring i alle patientrapporterede resultater (Health Assessment Questionnaire Disability Index – HAQ- DI, den korte version af SF- 36 og Functional Assessment of Chronic Illness Therapy Questionnaires).
Health-related and quality of life outcomes Tocilizumab-treated patients reported an improvement in all patient-reported outcomes (Health Assessment Questionnaire Disability Index - HAQ-DI), Short Form-36 and Functional Assessment of Chronic Illness Therapy questionnaires.